Daily Anesthesiology Research Analysis
Three perioperative studies stand out today: a distributional offline reinforcement learning system optimized insulin dosing after cardiac surgery and matched or exceeded senior clinicians in multi-phase validation; a prospective cohort linked cardiometabolic multimorbidity to postoperative delirium with cerebrospinal fluid T-tau partially mediating risk; and a population-based analysis showed higher surgeon–anesthesiologist dyad familiarity was associated with lower 90-day major morbidity for s
Summary
Three perioperative studies stand out today: a distributional offline reinforcement learning system optimized insulin dosing after cardiac surgery and matched or exceeded senior clinicians in multi-phase validation; a prospective cohort linked cardiometabolic multimorbidity to postoperative delirium with cerebrospinal fluid T-tau partially mediating risk; and a population-based analysis showed higher surgeon–anesthesiologist dyad familiarity was associated with lower 90-day major morbidity for several surgical categories.
Research Themes
- AI-driven perioperative decision support and insulin dosing
- Mechanisms and biomarkers of postoperative delirium
- Team familiarity and operating room outcomes
Selected Articles
1. A distributional reinforcement learning model for optimal glucose control after cardiac surgery.
GLUCOSE, a distributional offline reinforcement learning system, optimized insulin dosing after cardiac surgery, outperforming clinician policies in internal and external validations and achieving lower mean absolute dosing error in human validation. Performance was comparable to or exceeded senior clinicians across safety, effectiveness, and acceptability metrics.
Impact: Demonstrates robust, externally validated AI capable of improving a high-risk perioperative task (insulin dosing) and matching senior clinician performance, suggesting readiness for prospective clinical trials.
Clinical Implications: Could standardize and enhance postoperative glycemic management after cardiac surgery, potentially reducing hypo- and hyperglycemia-related complications when prospectively deployed with guardrails.
Key Findings
- Outperformed clinician policies in internal testing (estimated reward 0.0 vs −1.29) and external validation (−0.63 vs −1.02).
- Lower insulin dosing MAE than clinicians: 0.9 vs 1.97 units (internal, p<0.001) and 1.90 vs 2.24 units (external, p=0.003).
- Multi-phase human validation showed performance comparable to or exceeding senior clinicians in safety, effectiveness, and acceptability.
Methodological Strengths
- Large training, internal test, and external validation cohorts with prespecified metrics
- Multi-phase human validation against practicing clinicians including seniors
Limitations
- Offline retrospective validation without prospective clinical deployment
- Generalizability to other institutions and glucose protocols requires testing; safety in rare subgroups not fully characterized
Future Directions: Prospective, randomized or stepped-wedge trials with safety guardrails, clinician-in-the-loop workflows, and evaluation of hard clinical outcomes (hypoglycemia, infection, LOS, mortality).
This study introduces Glucose Level Understanding and Control Optimized for Safety and Efficacy (GLUCOSE), a distributional offline reinforcement learning algorithm for optimizing insulin dosing after cardiac surgery. Trained on 5228 patients, tested on 920, and externally validated on 649, GLUCOSE achieved a mean estimated reward of 0.0 [-0.07, 0.06] in internal testing and -0.63 [-0.74, -0.52] in external validation, outperforming clinician returns of -1.29 [-1.37, -1.20] and -1.02 [-1.16, -0.89]. In multi-phase human validation, GLUCOSE first showed a significantly lower me
2. Association of cardiometabolic multimorbidity with postoperative delirium and three-year mortality in patients undergoing knee/hip arthroplasty: a prospective cohort study.
In 875 arthroplasty patients, cardiometabolic multimorbidity was strongly associated with postoperative delirium (OR 5.06), with CSF T‑tau and P‑tau as risk factors and Aβ42 as protective. Mediation analysis suggested CSF T‑tau mediated ~11% of CMM’s effect on delirium, and a CMM subgroup (diabetes plus coronary heart disease) had higher 3‑year mortality among POD patients.
Impact: Links a common perioperative risk construct (cardiometabolic multimorbidity) to POD with mechanistic support via CSF tau, informing risk stratification and potential biomarker-guided interventions.
Clinical Implications: Preoperative identification of CMM and consideration of CSF biomarkers (e.g., T‑tau) could inform delirium prevention strategies and follow-up intensity, especially in diabetes plus coronary disease.
Key Findings
- CMM associated with POD: OR 5.062 (95% CI 3.279–7.661; P<0.001).
- CSF T‑tau and P‑tau were risk factors; Aβ42 was protective.
- Mediation: CSF T‑tau explained ~11% of CMM→POD pathway (P<0.05).
- Among POD patients (n=50), diabetes+coronary heart disease had higher 3‑year mortality (K‑M, P=0.004).
Methodological Strengths
- Prospective cohort with predefined analyses and sensitivity/post hoc checks
- Integration of CSF biomarkers and mediation analysis supporting mechanistic inference
Limitations
- Single database and setting; generalizability may be limited
- Three-year mortality analysis included a small POD subgroup (n=50)
Future Directions: Multicenter validation, evaluation of biomarker-guided prevention (e.g., tau-targeted strategies), and integration with multimodal delirium risk models.
INTRODUCTION: Postoperative delirium (POD) is a severe and common complication. This study aimed to investigate the association of cardiometabolic multimorbidity (CMM) and their different subgroups with POD. METHODS: This prospective cohort study ultimately included 875 patient samples from the Perioperative Neurocognitive Disorder and Lifestyle Biomarkers (PNDABLE) database, collected between July 2020 and September 2021. In this study, patients were first categorized into a POD group and a non-POD group, and the demographic characteristics of the two groups were compared. Next, logistic regression models were used to analyze the association between CMM and POD, as well as between cerebrospinal fluid (CSF) biomarkers and POD. Additionally, the models examined the relationship between different CMM subtypes and the incidence of POD. Subsequently, the robustness of the results was verified by sensitivity analysis and post hoc analysis. Further, the role of CSF biomarkers in the relationship between CMM and POD was assessed using mediation analysis. Finally, CMM patients with POD were followed up for three years, and Kaplan-Meier (K-M) survival analysis was used to compare the mortality rates of different CMM subgroups in patients with POD. RESULTS: Logistic regression analysis showed that CMM [odds ratio: 5.062; 95% CI: 3.279-7.661; P < 0.001], T-tau, and P-tau were risk factors for POD, while Aβ42 was a protective factor. Associations between different CMM subgroups and POD varied. Sensitivity and post hoc analyses supported these findings. Mediation analysis indicated that CMM could increase the incidence of POD through the CSF T-tau (proportion: 11%, P < 0.050). A follow-up of 50 patients showed that K-M survival analysis revealed that the POD patients in the diabetes combined with coronary heart disease group had a significantly higher three-year mortality compared to other CMM subgroups ( P = 0.004). CONCLUSIONS: CMM may be a risk factor for POD, with CSF T-tau potentially playing a mediating role. These findings underscore the importance of preoperative cognitive assessment for risk stratification and suggest CSF T-tau as a potential intervention target. Future studies may further explore intervention strategies targeting CMM and CSF T-tau.
3. Familiarity of the Surgeon-Anesthesiologist Dyad and Major Morbidity After High-Risk Elective Surgery.
Across 711,006 high-risk elective operations, higher surgeon–anesthesiologist dyad familiarity was independently associated with lower 90‑day major morbidity in low- and high‑risk GI, gynecologic oncology, and spine surgery. Each additional shared case reduced odds of major morbidity by 4% (low-risk GI), 8% (high-risk GI), and 3% (gynecologic oncology, spine).
Impact: Provides large-scale evidence that consistent surgeon–anesthesiologist pairing relates to better outcomes, informing OR staffing and scheduling strategies to improve safety.
Clinical Implications: Hospitals may consider structuring schedules to increase dyad consistency, particularly for GI, gynecologic oncology, and spine cases, while balancing staffing constraints.
Key Findings
- Population-based cohort of 711,006 high-risk elective procedures (2009–2019).
- Higher dyad familiarity associated with lower 90-day major morbidity in low-risk GI (OR 0.96), high-risk GI (OR 0.92), gynecologic oncology (OR 0.97), and spine (OR 0.97).
- No significant adjusted associations in other surgical categories; dyad volumes were generally low outside cardiac/orthopedic/lung.
Methodological Strengths
- Massive sample size with stratification by procedure type and multivariable adjustment
- Controls for hospital, surgeon, anesthesiologist volumes and patient factors
Limitations
- Retrospective observational design limits causal inference; potential unmeasured confounding
- Effect not observed across all surgical categories
Future Directions: Prospective evaluations of team-based scheduling models and mechanisms (communication, shared mental models) to harness dyad familiarity benefits.
IMPORTANCE: The surgeon-anesthesiologist teamwork is a core component of performance in the operating room, which can influence patient outcomes. OBJECTIVE: To examine the association between surgeon-anesthesiologist dyad familiarity (as dyad volume, the number of procedures done together) with 90-day postoperative major morbidity for high-risk elective surgery. DESIGN, SETTING, AND PARTICIPANTS: This population-based retrospective cohort study used administrative health care data from Ontario, Canada. Participants included high-risk elective operations (cardiac, low- and high- risk gastrointestinal [GI], genitourinary, gynecology oncology, neurosurgery, orthopedic, spine, vascular, and head and neck) from 2009 through 2019. Data were analyzed from January 2009 to March 2020. EXPOSURE: Dyad familiarity, as the annual volume of procedures done by the surgeon-anesthesiologist dyad in 4 years prior to index surgery. MAIN OUTCOMES AND MEASURES: 90-day major morbidity (any Clavien-Dindo grade 3 to 5). The association between exposure and outcome was examined using multivariable logistic regression, stratified by type of procedure. RESULTS: Among 711 006 index procedures, the median dyad volume and rate of 90-day major morbidity varied by type of procedure. There was higher median volume and dyad consistency for cardiac, orthopedic, and lung surgery. For other procedures, the median dyad volume was low (3 or less procedures per dyad per year). An independent association was observed between dyad volume and 90-day major morbidity for high-risk GI surgery (odds ratio [OR], 0.92; 95% CI, 0.88-0.96), low-risk GI surgery (OR, 0.96; 95% CI, 0.95-0.98), gynecology oncology surgery (OR, 0.97; 95% CI, 0.94-0.99), and spine surgery (OR, 0.97; 95% CI, 0.96-0.99), after adjusting for hospital setting, hospital, surgeon and anesthesiologist volume, and patient age, sex, and comorbidity burden. The adjusted associations were not significant for other types of procedures. CONCLUSIONS AND RELEVANCE: In this study, increasing familiarity of the surgeon-anesthesiologist dyad was associated with improved postoperative outcomes for patients undergoing low- and high-risk GI surgery, gynecology oncology surgery, and spine surgery. For each additional time that a unique surgeon-anesthesiologist dyad worked together, the odds of 90-day major morbidity decreased by 4% for low-risk GI surgery, 8% for high-risk GI surgery, 3% for gynecology oncology surgery, and 3% for spine surgery. Additional research is needed to determine the most effective care structures that harness the benefits of surgeon-anesthesiologist familiarity to potentially improve patient outcomes.